Li Z - Search Results

1

Design, synthesis and structure-activity relationship studies of novel phenoxyacetamide-based free fatty acid receptor 1 agonists for the treatment of type 2 diabetes.

Li Z, Wang X, Xu X, Yang J, Qiu Q, Qiang H, Huang W, Qian H. Li Z, et al. Bioorg Med Chem. 2015 Oct 15;23(20):6666-72. doi: 10.1016/j.bmc.2015.09.010. Epub 2015 Sep 5. Bioorg Med Chem. 2015. PMID: 26420383

2

Design, synthesis, and biological activity of novel dicoumarol glucagon-like peptide 1 conjugates.

Han J, Sun L, Chu Y, Li Z, Huang D, Zhu X, Qian H, Huang W. Han J, et al. Among authors: li z. J Med Chem. 2013 Dec 27;56(24):9955-68. doi: 10.1021/jm4017448. Epub 2013 Dec 13. J Med Chem. 2013. PMID: 24308627

3

C-Aryl Glucosides with Substituents at the Distal Aryl Ring as Sodium-Dependent Glucose Cotransporter Inhibitors for the Treatment of Diabetes Mellitus.

Wang X, Li Y, Yang B, Li Z, Huang W, Qian H. Wang X, et al. Among authors: li y, li z. Chem Biol Drug Des. 2015 Aug;86(2):246-53. doi: 10.1111/cbdd.12487. Epub 2014 Dec 18. Chem Biol Drug Des. 2015. PMID: 25443983

4

Synthesis and biological evaluation of phenoxyacetic acid derivatives as novel free fatty acid receptor 1 agonists.

Wang X, Zhao T, Yang B, Li Z, Cui J, Dai Y, Qiu Q, Qiang H, Huang W, Qian H. Wang X, et al. Among authors: li z. Bioorg Med Chem. 2015 Jan 1;23(1):132-40. doi: 10.1016/j.bmc.2014.11.016. Epub 2014 Nov 20. Bioorg Med Chem. 2015. PMID: 25481394

5

Design, Synthesis and in vivo Evaluation of Novel C-Aryl Glucosides as Potent Sodium-Dependent Glucose Cotransporters Inhibitors for the Treatment of Diabetes.

Li Z, Wang X, Xu X, Qiu Q, Jiao L, Huang W, Qian H. Li Z, et al. Chem Biol Drug Des. 2015 Oct;86(4):764-75. doi: 10.1111/cbdd.12547. Epub 2015 Mar 20. Chem Biol Drug Des. 2015. PMID: 25732240

6

Design, synthesis and biological activity of phenoxyacetic acid derivatives as novel free fatty acid receptor 1 agonists.

Li Z, Wang X, Xu X, Yang J, Xia W, Zhou X, Huang W, Qian H. Li Z, et al. Bioorg Med Chem. 2015 Nov 15;23(22):7158-64. doi: 10.1016/j.bmc.2015.10.011. Epub 2015 Oct 8. Bioorg Med Chem. 2015. PMID: 26482570

7

Design, synthesis and Structure-activity relationship studies of new thiazole-based free fatty acid receptor 1 agonists for the treatment of type 2 diabetes.

Li Z, Qiu Q, Xu X, Wang X, Jiao L, Su X, Pan M, Huang W, Qian H. Li Z, et al. Eur J Med Chem. 2016 May 4;113:246-57. doi: 10.1016/j.ejmech.2016.02.040. Epub 2016 Feb 21. Eur J Med Chem. 2016. PMID: 26945112

8

Discovery of novel pyrrole-based scaffold as potent and orally bioavailable free fatty acid receptor 1 agonists for the treatment of type 2 diabetes.

Li Z, Pan M, Su X, Dai Y, Fu M, Cai X, Shi W, Huang W, Qian H. Li Z, et al. Bioorg Med Chem. 2016 May 1;24(9):1981-7. doi: 10.1016/j.bmc.2016.03.014. Epub 2016 Mar 7. Bioorg Med Chem. 2016. PMID: 27020683

9

Free fatty acid receptor agonists for the treatment of type 2 diabetes: drugs in preclinical to phase II clinical development.

Li Z, Qiu Q, Geng X, Yang J, Huang W, Qian H. Li Z, et al. Expert Opin Investig Drugs. 2016 Aug;25(8):871-90. doi: 10.1080/13543784.2016.1189530. Epub 2016 May 27. Expert Opin Investig Drugs. 2016. PMID: 27171154 Review.

10

Discovery of novel free fatty acid receptor 1 agonists bearing triazole core via click chemistry.

Li Z, Yang J, Wang X, Li H, Liu C, Wang N, Huang W, Qian H. Li Z, et al. Among authors: li h. Bioorg Med Chem. 2016 Nov 1;24(21):5449-5454. doi: 10.1016/j.bmc.2016.08.068. Epub 2016 Sep 1. Bioorg Med Chem. 2016. PMID: 27624524

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

113,477 results

Search Page

Filters